Company News

bioMérieux, a world leader in the field of in-vitro diagnostics, today announced that it has received the first-ever cannabis-related Performance Tested MethodsSM (PTM) validation for the enumeration of yeasts and molds for its TEMPO® YM Assay (PTM 041001) by the AOAC INTERNATIONAL’s Emergency Response Validation (ERV) program.

Invisible Sentinel, a bioMérieux Company, drove the innovation for the first method approved by the AOAC Research Institute Performance Tested Methods℠,(PTM) for the analysis of cannabis flower for pathogenic Aspergillus spp. within the marketplace, the assay is aptly named the GENE-UP® AspergillusPRO.

As the cannabis and hemp industry grow exponentially, the need for consumer safety is now more important than ever. Supporting that need for product and consumer safety, bioMérieux, a world leader in the field of in vitro diagnostics, received approval from the AOAC Research Institute Performance Tested Methods℠ (PTM) for the detection of Salmonella and STEC (Shiga toxin-producing E. coli) contaminants in cannabis flower and whole hemp flower utilizing GENE-UP® SLM2 (PTM 121802) and EHEC (PTM 121806) assays.